AU2002234476A1 - Medical aerosol formulations - Google Patents

Medical aerosol formulations

Info

Publication number: AU2002234476A1
Authority: AU; Australia
Prior art keywords: aerosol formulations; medical aerosol; medical; formulations; aerosol
Prior art date: 2001-03-30
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Granted

Application number

AU2002234476A

Other versions

AU2002234476C1 (en

AU2002234476B2 (en

Inventor

Rudi Muller-Walz

Carsten Niederlander

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Jagotec AG

Original Assignee

Jagotec AG

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-03-30

Filing date

2002-03-11

Publication date

2003-04-03

2002-03-11 Application filed by Jagotec AG filed Critical Jagotec AG

2002-03-11 Priority claimed from PCT/CH2002/000145 external-priority patent/WO2002078671A1/en

2002-10-15 Publication of AU2002234476C1 publication Critical patent/AU2002234476C1/en

2003-04-03 Publication of AU2002234476A1 publication Critical patent/AU2002234476A1/en

2006-04-27 Application granted granted Critical

2006-04-27 Publication of AU2002234476B2 publication Critical patent/AU2002234476B2/en

2022-03-11 Anticipated expiration legal-status Critical

Status Ceased legal-status Critical Current

Links

239000000443 aerosol Substances 0.000 title 1
239000000203 mixture Substances 0.000 title 1

AU2002234476A 2001-03-30 2002-03-11 Medical aerosol formulations Ceased AU2002234476B2 (en)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
CH6012001		2001-03-30
CH601/01		2001-03-30
CH1527/01		2001-08-20
CH15272001		2001-08-20
PCT/CH2002/000145 WO2002078671A1 (en)	2001-03-30	2002-03-11	Medical aerosol formulations

Publications (3)

Publication Number	Publication Date
AU2002234476C1 AU2002234476C1 (en)	2002-10-15
AU2002234476A1 true AU2002234476A1 (en)	2003-04-03
AU2002234476B2 AU2002234476B2 (en)	2006-04-27

Family

ID=25737693

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2002234476A Ceased AU2002234476B2 (en)	2001-03-30	2002-03-11	Medical aerosol formulations

Country Status (23)

Country	Link
US (1)	US20040101483A1 (en)
EP (1)	EP1372608B1 (en)
JP (1)	JP4824267B2 (en)
CN (1)	CN100496608C (en)
AT (1)	ATE375142T1 (en)
AU (1)	AU2002234476B2 (en)
CA (1)	CA2442415C (en)
CY (1)	CY1107128T1 (en)
CZ (1)	CZ301676B6 (en)
DE (1)	DE50211045D1 (en)
DK (1)	DK1372608T3 (en)
ES (1)	ES2292713T3 (en)
HK (1)	HK1064295A1 (en)
HU (1)	HU229798B1 (en)
NO (1)	NO332848B1 (en)
NZ (1)	NZ528640A (en)
PL (1)	PL207377B1 (en)
PT (1)	PT1372608E (en)
RO (1)	RO121172B1 (en)
RU (1)	RU2294737C2 (en)
SK (1)	SK286394B6 (en)
WO (1)	WO2002078671A1 (en)
ZA (1)	ZA200307161B (en)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20070212422A1 (en) *	1999-11-10	2007-09-13	Manfred Keller	Dry powder for inhalation
WO2003024396A2 (en)	2001-09-17	2003-03-27	Glaxo Group Limited	Dry powder medicament formulations
GB0208609D0 (en) *	2002-04-13	2002-05-22	Glaxo Group Ltd	Compositions
WO2004052835A1 (en) *	2002-12-10	2004-06-24	Sepracor Inc.	Levalbuterol salt
EP1646370A1 (en) *	2003-07-11	2006-04-19	Glaxo Group Limited	Pharmaceutical formulations
GB0316335D0 (en) *	2003-07-11	2003-08-13	Glaxo Group Ltd	Pharmaceutical formulations
GB0323685D0 (en) *	2003-10-09	2003-11-12	Jagotec Ag	Improvements in or relating to organic compounds
GB0323684D0 (en)	2003-10-09	2003-11-12	Jagotec Ag	Improvements in or relating to organic compounds
GB0324918D0 (en) *	2003-10-24	2003-11-26	Glaxo Group Ltd	Composition
PT1713473E (en)	2004-02-06	2013-05-13	Meda Pharma Gmbh & Co Kg	The combination of anticholinergics and glucocorticoids for the long-term treatment of asthma and copd
JP5524442B2 (en) *	2004-02-06	2014-06-18	メダファーマゲゼルシャフトミットベシュレンクテルハフツングウントコンパニーコマンディトゲゼルシャフト	Novel combination of anticholinergic and beta-mimetic for the treatment of respiratory diseases
CN100512813C (en)	2004-02-06	2009-07-15	Meda制药有限及两合公司	Combination of anticholinergics and inhibitors of phosphodiesterase type 4 for the treatment of respiratory diseases
GB0409703D0 (en) *	2004-04-30	2004-06-02	Vectura Ltd	Pharmaceutical compositions
GB0426301D0 (en) *	2004-11-30	2004-12-29	Vectura Ltd	Pharmaceutical formulations
GB0501956D0 (en) *	2005-01-31	2005-03-09	Arrow Internat	Nebulizer formulation
SI1863476T1 (en)	2005-03-16	2016-05-31	Meda Pharma Gmbh & Co. Kg	The combination of anticholinergics and leukotriene receptor antagonists for the treatment of respiratory diseases
AU2006315657B2 (en) *	2005-11-10	2011-12-01	Shell Internationale Research Maatschappij B.V.	Soft anticholinergic esters
AU2012200449B2 (en) *	2005-12-21	2013-07-25	Meda Pharma Gmbh & Co Kg	Combination of anticholinergics, glucocorticoids, beta2-agonists, PDE4 inhibitor and antileukotriene for the treatment of inflammatory diseases
ES2389231T3 (en)	2005-12-21	2012-10-24	Meda Pharma Gmbh & Co. Kg	Combination of anticholinergics, glucocorticoids and beta2 agonists for the treatment of inflammatory diseases
GB0602897D0 (en) *	2006-02-13	2006-03-22	Jagotec Ag	Improvements In Or Relating To Dry Powder Inhaler Devices
GB0622818D0 (en) *	2006-11-15	2006-12-27	Jagotec Ag	Improvements in or relating to organic compounds
GB0625303D0 (en) *	2006-12-19	2007-01-24	Jagotec Ag	Improvements in and relating to metered dose inhalers
AU2015201864A1 (en) *	2009-05-29	2015-04-30	Pearl Therapeutics, Inc.	Compositions for pulmonary delivery of long-acting muscarinic antagonists and long-acting B2 adrenergic receptor agonists and associated methods and systems
AU2015201037C1 (en) *	2009-05-29	2017-07-27	Pearl Therapeutics, Inc.	Respiratory delivery of active agents
US8815258B2 (en)	2009-05-29	2014-08-26	Pearl Therapeutics, Inc.	Compositions, methods and systems for respiratory delivery of two or more active agents
US9463161B2 (en) *	2009-05-29	2016-10-11	Pearl Therapeutics, Inc.	Compositions for pulmonary delivery of long-acting muscarinic antagonists and associated methods and systems
GB0918149D0 (en) *	2009-10-16	2009-12-02	Jagotec Ag	Improved medicinal aerosol formulation
GB0918150D0 (en) *	2009-10-16	2009-12-02	Jagotec Ag	Improved formulations
PE20121467A1 (en)	2009-12-23	2012-11-07	Chiesi Farma Spa	AEROSOL FORMULATION FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE
EA021917B1 (en)	2009-12-23	2015-09-30	КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А.	Combination therapy for asthma and copd
CN102695496B (en) *	2009-12-23	2014-10-01	奇斯药制品公司	Aerosol formulation for COPD
JP5513177B2 (en) *	2010-03-08	2014-06-04	共同印刷株式会社	Humidity indicator and method for producing the same, and paint for humidity indicator used in the production method
CN102416179B (en)	2010-09-28	2014-05-07	益得生物科技股份有限公司	Inhaled compound composition for asthma
SI2765994T1 (en)	2011-10-11	2019-02-28	Chiesi Farmaceutici S.P.A.	Crystalline microparticles of a beta-agonist coated with a fatty acid
CN102362860A (en) *	2011-10-27	2012-02-29	江阴长风医药科技有限公司	Budesonide and formoterol aerosol preparation taking hydro-fluoro-alkane as propellant
JP6454323B2 (en)	2013-03-15	2019-01-16	パールセラピューティクス，インコーポレイテッド	Method and system for conditioning particulate crystalline materials
US20190099344A1 (en) *	2016-04-11	2019-04-04	Suven Life Sciences Limited	Topical spray formulation of glycopyrrolate

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS55361B1 (en) *	1970-09-17	1980-01-08
US5874063A (en) *	1991-04-11	1999-02-23	Astra Aktiebolag	Pharmaceutical formulation
SE9302777D0 (en) *	1993-08-27	1993-08-27	Astra Ab	Process for conditioning substances
EP0561166A1 (en) *	1992-03-17	1993-09-22	ASTA Medica Aktiengesellschaft	Aerosol compositions containing compound D-18024 and its analogs
MX9304585A (en) *	1992-07-31	1994-03-31	Glaxo Group Ltd	PHARMACEUTICAL FORMULATION IN AEROSOL, CAN SUITABLE TO RELEASE THE FORMULATION AND INHALER OF DOSE DOSE THAT COMPRISES THE CAN.
JPH06135815A (en) *	1992-10-30	1994-05-17	Shiseido Co Ltd	Percutaneous absorption suppressing composition
ZA939195B (en) *	1992-12-09	1995-06-08	Boehringer Ingelheim Pharma	Stabilized medicinal aerosol solution formulations
DE4321288A1 (en) *	1993-06-26	1995-01-05	Solvay Fluor & Derivate	Compositions with chlorine-free, optionally hydrogen-containing fluorocarbons
JPH09506097A (en) *	1993-12-02	1997-06-17	アボツト・ラボラトリーズ	Aerosol drug formulation for use with non-CFC propellants
US5589156A (en) *	1994-05-02	1996-12-31	Henry; Richard A.	Prilocaine and hydrofluourocarbon aerosol preparations
NZ298169A (en) *	1994-12-22	1999-09-29	Astra Ab	Aerosol drug formulation; comprises hydrofluoroalkane propellant, medicament for inhalation and a surfactant
US6524557B1 (en) *	1994-12-22	2003-02-25	Astrazeneca Ab	Aerosol formulations of peptides and proteins
JP3707107B2 (en) *	1995-09-18	2005-10-19	鈴木油脂工業株式会社	Pharmaceutical dispersion and method for producing the same
US6054488A (en) *	1996-06-11	2000-04-25	3M Innovative Properties Company	Medicinal aerosol formulations of formoterol
US6261472B1 (en) *	1996-11-04	2001-07-17	E. I. Du Pont De Nemours And Company	Azeotrope-like compositions containing fluoroethane
US6361938B1 (en) *	1996-11-08	2002-03-26	Elan Corporation, Plc	Peptides which enhance transport across tissues and methods of identifying and using the same
GB2337201B (en) *	1997-01-30	2001-02-14	Alpenstock Holdings Ltd	Haemostatic aerosol composition
WO1998034595A1 (en) *	1997-02-05	1998-08-13	Jago Research Ag	Medical aerosol formulations
US6086376A (en) *	1998-01-30	2000-07-11	Rtp Pharma Inc.	Dry aerosol suspension of phospholipid-stabilized drug microparticles in a hydrofluoroalkane propellant
US6451285B2 (en) *	1998-06-19	2002-09-17	Baker Norton Pharmaceuticals, Inc.	Suspension aerosol formulations containing formoterol fumarate and a fluoroalkane propellant
ES2234266T3 (en) *	1998-07-24	2005-06-16	Jago Research Ag	MEDICAL FORMULATIONS FOR AEROSOLS.
EP1102579B1 (en) *	1998-08-04	2003-03-19	Jago Research Ag	Medicinal aerosol formulations
US7521068B2 (en) *	1998-11-12	2009-04-21	Elan Pharma International Ltd.	Dry powder aerosols of nanoparticulate drugs
US6926911B1 (en) *	1998-12-22	2005-08-09	The University Of North Carolina At Chapel Hill	Compounds and methods for the treatment of airway diseases and for the delivery of airway drugs
GB9903759D0 (en) *	1999-02-18	1999-04-14	Novartis Ag	Organic compounds
HU230804B1 (en) *	2000-05-22	2018-06-28	Chiesi Farmaceutici S.P.A	Stable pharmaceutical solution formulations for pressurised metered dose inhalers
US20060257324A1 (en) *	2000-05-22	2006-11-16	Chiesi Farmaceutici S.P.A.	Pharmaceutical solution formulations for pressurised metered dose inhalers
CA2417973A1 (en) *	2000-08-04	2002-02-14	Longwood Pharmaceutical Research, Inc.	Formulations of mometasone and a bronchodilator for pulmonary administration
AU2002222115B2 (en) *	2000-11-30	2006-09-28	Vectura Limited	Method of making particles for use in a pharmaceutical composition
AR036358A1 (en) *	2001-08-28	2004-09-01	Schering Corp	A DOSE INHALER MEASURES CONTAINING A SUSPENSION FORMULATION IN AEROSOL FOR INHALATION, A PROCESS FOR THE PRODUCTION OF THE FORMULATION, THE PRODUCT AND THE USE OF A FORMULATION FOR THE MANUFACTURE OF AN ASTHMA MEDICINAL PRODUCT
JP2005523905A (en) *	2002-03-01	2005-08-11	キエシ・フアルマチエウテイチ・ソチエタ・ペル・アチオニ	Formoterol ultrafine formulation
US7582284B2 (en) *	2002-04-17	2009-09-01	Nektar Therapeutics	Particulate materials
GB0323684D0 (en) *	2003-10-09	2003-11-12	Jagotec Ag	Improvements in or relating to organic compounds
GB0323685D0 (en) *	2003-10-09	2003-11-12	Jagotec Ag	Improvements in or relating to organic compounds
GB0918150D0 (en) *	2009-10-16	2009-12-02	Jagotec Ag	Improved formulations
GB0918149D0 (en) *	2009-10-16	2009-12-02	Jagotec Ag	Improved medicinal aerosol formulation

2002
- 2002-03-11 DE DE50211045T patent/DE50211045D1/en not_active Expired - Lifetime
- 2002-03-11 AT AT02701145T patent/ATE375142T1/en active
- 2002-03-11 PT PT02701145T patent/PT1372608E/en unknown
- 2002-03-11 PL PL362797A patent/PL207377B1/en unknown
- 2002-03-11 ES ES02701145T patent/ES2292713T3/en not_active Expired - Lifetime
- 2002-03-11 SK SK1334-2003A patent/SK286394B6/en not_active IP Right Cessation
- 2002-03-11 EP EP02701145A patent/EP1372608B1/en not_active Expired - Lifetime
- 2002-03-11 JP JP2002576937A patent/JP4824267B2/en not_active Expired - Fee Related
- 2002-03-11 US US10/473,874 patent/US20040101483A1/en not_active Abandoned
- 2002-03-11 WO PCT/CH2002/000145 patent/WO2002078671A1/en active IP Right Grant
- 2002-03-11 NZ NZ528640A patent/NZ528640A/en not_active IP Right Cessation
- 2002-03-11 HU HU0401250A patent/HU229798B1/en not_active IP Right Cessation
- 2002-03-11 AU AU2002234476A patent/AU2002234476B2/en not_active Ceased
- 2002-03-11 RU RU2003131676/15A patent/RU2294737C2/en not_active IP Right Cessation
- 2002-03-11 CN CNB028073827A patent/CN100496608C/en not_active Expired - Fee Related
- 2002-03-11 DK DK02701145T patent/DK1372608T3/en active
- 2002-03-11 CZ CZ20032915A patent/CZ301676B6/en not_active IP Right Cessation
- 2002-03-11 RO ROA200300799A patent/RO121172B1/en unknown
- 2002-03-11 CA CA2442415A patent/CA2442415C/en not_active Expired - Fee Related
2003
- 2003-09-12 ZA ZA2003/07161A patent/ZA200307161B/en unknown
- 2003-09-26 NO NO20034323A patent/NO332848B1/en not_active IP Right Cessation
2004
- 2004-09-17 HK HK04107112.4A patent/HK1064295A1/en not_active IP Right Cessation
2008
- 2008-01-08 CY CY20081100021T patent/CY1107128T1/en unknown

Publication	Publication Date	Title
AU2002234476A1 (en)	2003-04-03	Medical aerosol formulations
WO2002089880A8 (en)	2003-04-03	Inhalers
AU2002313236A1 (en)	2003-05-15	Medicinal compositions
AU6310000A (en)	2001-03-05	Aerosol formulations
AU2002330273A1 (en)	2003-04-22	Liposome-encapsulated insulin formulations
AU2002365120A1 (en)	2003-07-15	Medicaments
AU2002257582A1 (en)	2002-09-04	Pharmaceutical formulation
AU2002253039A1 (en)	2003-02-27	Tramadol-based medicament
AU2002258221A1 (en)	2003-05-08	Medicinal composition
GB0103638D0 (en)	2001-03-28	Pharmaceutical formulations
AU2002225025A1 (en)	2003-03-06	Agrochemical formulations
GB0105560D0 (en)	2001-04-25	Pharmaceutical formulations
AU1141101A (en)	2001-04-30	Pharmaceutical aerosol formulations comprising s-salmeterol
AU2001247841A1 (en)	2001-10-30	Medical procedure
AU2002302569A1 (en)	2002-11-11	Antiperspirant formulations
AU2002354460A1 (en)	2003-07-09	Medicinal composition
AU2002238748A1 (en)	2002-09-24	Pharmaceutical aerosol formulation
AU2002346223A1 (en)	2003-05-15	Medicinal compositions
GB0128582D0 (en)	2002-01-23	Pharmaceutical aerosol formulations
GB0128612D0 (en)	2002-01-23	Aerosol formulations
AU2002306341A1 (en)	2002-12-23	Medicinal compositions
AU2002327341A1 (en)	2003-02-24	Thrombomodulin-containing medicinal compositions
AU2002256916A1 (en)	2002-12-09	Medicinal compositions
AU2002235413A1 (en)	2002-07-30	Medicinal aerosols
AUPR310501A0 (en)	2001-03-08	Medical composition